According to Allakos's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.17 B | -38.96% |
2022-12-31 | $0.27 B | -34.05% |
2021-12-31 | $0.42 B | -35.62% |
2020-12-31 | $0.65 B | 32.89% |
2019-12-31 | $0.49 B | 177.19% |
2018-12-31 | $0.17 B | 109.97% |
2017-12-31 | $85.2 M | 535.11% |
2016-12-31 | $13.41 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $75.63 M | -45.68% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $16.39 M | -88.23% | ๐บ๐ธ USA |